When is Helicobacter Senioren actually useful?

The question of when Helicobacter pylori testing is useful in seniors cannot be answered universally. H. pylori colonizes the gastric mucosa and is linked to gastritis, peptic ulcers, and gastric cancer. In elderly patients (>65 years), evidence for routine screening is weak. Clinical guidelines (e.g., from DGVS) recommend testing only in symptomatic individuals with dyspepsia, unexplained epigastric pain, or confirmed ulcer disease. Routine screening of asymptomatic seniors is not advised because prevalence is high but most carriers remain asymptomatic. Additionally, older age increases risks of antibiotic resistance and adverse effects from eradication therapy. MyBody-X may offer an H. pylori test, but its clinical utility for asymptomatic seniors is questionable. A positive result alone does not mandate treatment; individual risk-benefit assessment is essential. Caution against overdiagnosis and unnecessary antibiotic use. Evidence: unclear, based on current guidelines.